A possible protective effect of KL-VS heterozygosity on tau accumulation has been explored to a lesser extent,13,14 and we are the first, to our knowledge, to report an association between CSF Klotho levels and CSF T-tau and P-tau levels in a clinical cohort with AD. Here, MAPT is linked to Alzheimer disease.